- Home
- MPT vs VKTX Comparison
MPT vs VKTX Comparison
Compare MPT & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MPT | VKTX |
|---|---|---|
| Founded | 2003 | 2012 |
| Country | United States | United States |
| Employees | 121 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.3B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | MPT | VKTX |
|---|---|---|
| Price | $5.07 | $32.79 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $5.00 | ★ $95.86 |
| AVG Volume (30 Days) | ★ 5.2M | 2.1M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | ★ 6.43% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.91 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.51 | $22.96 |
| 52 Week High | $6.47 | $43.15 |
Technical Indicators
Market Signals| Indicator | MPT | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.31 | 56.83 |
| Support Level | $4.92 | $29.32 |
| Resistance Level | $5.37 | $36.56 |
| Average True Range (ATR) | 0.14 | 1.24 |
| MACD | -0.01 | 0.34 |
| Stochastic Oscillator | 33.87 | 93.00 |
Price Performance
Historical ComparisonAbout MPT Medical Properties Trust Inc. common stock
Medical Properties Trust Inc acquires and develops net-leased healthcare facilities. Its investments in healthcare real estate, other loans, and any investments in tenants are considered a single reportable segment. Its business strategy is to acquire and develop healthcare facilities and lease the facilities to healthcare operating companies under long-term net leases, which require the tenant to bear of the costs associated with the property. The group's geographic areas are the United States, the United Kingdom, and All other countries.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.